Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Radiosynthesize of a novel antisense imaging probe targeting lncRNA HOTAIR in malignant glioma.

Qian Zhao, Jiongyu Ren, Haiyan Yang, Jiang Cao, Jiali Tian, Yaping Yu, Fulu Zhang and Juan Li
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1063;
Qian Zhao
1Department of Nuclear Medicine General Hospital of Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiongyu Ren
2Postgraduate College Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haiyan Yang
2Postgraduate College Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiang Cao
2Postgraduate College Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiali Tian
2Postgraduate College Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaping Yu
2Postgraduate College Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fulu Zhang
2Postgraduate College Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Li
1Department of Nuclear Medicine General Hospital of Ningxia Medical University Yinchuan, Ningxia China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1063

Objectives: Long non-coding RNA (lncRNA) HOTAIR was manifested overexpressing and amplifying in many human carcinomas, which could serve as a useful target for cancer therapy. The 99mTc radiolabeled antisense oligonucleotides (ASON) could visualize the expression of HOTAIR and provide a diagnostic and therapeutic value for malignant tumors. The aim of this study was to radiosynthesize 99mTc with HOTAIR ASON and investigate the influence of the probe in cell proliferation, migration in malignant glioma cells, and in vivo imaging in malignant glioma xenographs.

Methods: The ASON probe targeting lncRNA HOTAIR was designed and modified. The radiolabeling of 99mTc with HOTAIR ASON was via the conjugation of bifunctional chelator HYNIC. Then, the probe was purified and tested for its radiolabeling efficiency and purity, as well as stability by iTLC and gel electrophoresis by Sephadex G25. The radiolabeled and unlabeled probe were transfected to malignant glioma cell line U87 with lipofectamine 2000 for the next experimental use. CCK-8 assay and cell scratch test were used to detect the cell proliferation and migration. Furthermore, in vivo tumor imaging was performed after U87 tumor bearing nude mice models established at 0.5, 1, 2, 4 and 6 hours after the probe intravenous injection. All data were analyzed by statistical software.

Results: The labeling efficiencies of 99mTc-HYNIC-HOTAIR ASON was 75.3% ± 5.6% and the radiochemical purity was more than 95%. The probe showed good stability within 12 hours for high radiochemical purity. Gel electrophoresis confirmed that the oligomer was successfully radiolabeled no significant degradation was found. When compared with untransfected ASON, the expression level of HOTAIR, cell proliferation and cell migration decreased in both transfected 99mTc labeled and unlabeled probe groups. The tumor was clearly shown at 2 hours post probe injection on SPECT/CT imaging, compared with control and blocking group.

Conclusions: HOTAIR ASON can inhibit the cell migration and cell proliferation of glioma U87 cell line. The 99mTc-HYNIC-HOTAIR ASON probe can be radiosynthesized and used in the in vivo, real-time imaging of lncRNA HOTAIR expression in malignant glioma.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiosynthesize of a novel antisense imaging probe targeting lncRNA HOTAIR in malignant glioma.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiosynthesize of a novel antisense imaging probe targeting lncRNA HOTAIR in malignant glioma.
Qian Zhao, Jiongyu Ren, Haiyan Yang, Jiang Cao, Jiali Tian, Yaping Yu, Fulu Zhang, Juan Li
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1063;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiosynthesize of a novel antisense imaging probe targeting lncRNA HOTAIR in malignant glioma.
Qian Zhao, Jiongyu Ren, Haiyan Yang, Jiang Cao, Jiali Tian, Yaping Yu, Fulu Zhang, Juan Li
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1063;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Simplifying and Confirming Ketosis: A Quality Improvement Initiative in Cardiac Sarcoid Assessment
Show more

Preclinical Probes for Oncology (Poster Session)

  • Radiopharmacological evaluation of a novel caspase responsive probe for PET imaging of tumor apoptosis
  • Discriminating ALK-positive NSCLC Tumor with a PET Radioligand [18F]FPC
  • Radiosynthesis and Bioevaluation of Glucose-modified Gold Nanoparticles
Show more Preclinical Probes for Oncology (Poster Session)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire